- October 12, 2022
Feedback from Bioproduction conference
End of September, we attended the 7 th edition of conference Bioproduction organized by MabDesign , in Lyon . The focus this year was on the development and bioproduction of therapeutics drugs such as mAbs . There were several presentations both from SME and large biopharma groups and a section...
- September 14, 2022
Boosting a process with digital tools: Purification of oligonucleotides by ion exchange
Purification of oligonucleotides by ion exchange (IEX) is complex and many operating parameters need to be selected. There is a high interest in developing digital tools allowing to speed up process development, securing scale-up and decreasing waste. We present an innovative mechanistic model...
- September 12, 2022
Interviewing experts on DSP intensification
Process intensification allows biomanufacturers to produce more product, often more quickly, using fewer raw materials and smaller equipment in less space. While there has been much focus on upstream process intensification, this approach can have significant impacts for downstream processing as well...
- July 13, 2022
Roundtable : What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
In this roundtable from the new Q2 2022 issue of Pharma's Almanac , a distinguished panel of industry experts discusses the biggest challenge currently faced by the pharma/biopharma industry. The panel represents a diverse range of companies, including Ypso-Facto. The biopharmaceutical industry...
- July 05, 2022
The history of Novasep through the eyes of its founder Roger-Marc Nicoud
In this exclusive document, Roger-Marc Nicoud returns to the saga of Novasep, a group he founded in 1996 but in which he no longer plays any part. In April 2022, following its purchase by investment company Bridgepoint (financial shareholder of PharmaZell), the French group Novasep...
- June 28, 2022
Ypso-Ionic® - what our users say!
Ypso-Ionic® is a software solution for designing chromatographic processes. It maximizes the value of experimental data and makes predictive simulation a game changer. But the best people to talk about it... are our customers! Check out the feedback ! "Ypso-Facto® have developed a unique...
- June 08, 2022
Article : Digital tools support rational catalytic process development and evaluation
By Kilian Kobl - Project Manager at Ypso-Facto Progress in catalysis has enabled major breakthroughs in domains as various as agriculture, health and daily life, to only cite a few. Although new approaches of studying and developing catalytic processes emerge from time to time, people generally...
- May 04, 2022
6 facts you didn’t know about Ypso-Facto
How great would it be to have a way to check if your chemical and bioprocess is optimized, safe, green and efficient? Well, that’s what we do for you at Ypso-Facto ! Ypso-Facto means Y our P rocess S ecured and O ptimized …And it’s a FACT ! Ypso-Facto is a company which...
- April 28, 2022
Article : Digital tools unleash the full potential of oligonucleotide production
By Kilian Kobl - Project Manager at Ypso-Facto Current oligo manufacturing processes are still somewhat larger scale versions of the initial processes conceived in the lab. Oftentimes, during development of an API, the choice of speed had to be made at the expense of conceiving a process that produces...
Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.